Discover

JAGX
Jaguar Health, Inc.
3.04
2 x 2.17
2 x 3.77
bid
ask
+
0.04
1.33%
2 @ 05:39 AM
3.04 +0.00 (0.00%)
Ytd-90.67%
1y-96.53%
2.86
day range
3.07
2.12
52 week range
97.65
Open2.91Prev Close3.00Low2.86High3.07Mkt Cap14.65M
Vol47.77KAvg Vol89.87KEPS-695.50P/EN/AForward P/E-0.37
Beta0.88Short Ratio1.12Inst. Own1.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg4.40200-d Avg31.571yr Est6.00

JAGX News

Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
accessnewswire.com
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Hea

Company remains sharply focused on its ongoing global development program for crofelemer for rare IF

Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy
benzinga.com
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9

Major M&A deals this week include: Adobe buys Topaz Labs, Rise Baking Company purchases Jimmy&#3

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
accessnewswire.com
Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time

Company remains sharply focused on its ongoing global development program for crofelemer for rare in

benzinga.com
Jaguar Health Submits New Animal Drug Application To FDA For Veterinary Medicine For Full Approval O

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the company has completed

benzinga.com
Jaguar Health Board Initiates Process To Mull, Review Strategic Options

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that i

benzinga.com
Jaguar Health Board Initiates Review Of Strategic Alternatives To Maximize Shareholder Value, Aligne

Reminder: Lisa Conte, Jaguar's founder & CEO, to present on June 24, 2026 at the Life Scienc

benzinga.com
Jaguar Health Announces Data From Preclinical Study Initiates By Magdalena Biosciences Shows Novel E

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the results of a preclinic

benzinga.com
Jaguar Health CEO To Present At Life Sciences Virtual Investor Forum

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, presid